Pancreatic Cancer

Pancreatic Cancer

Adding SBRT to Chemotherapy Reduces Locoregional Recurrence in High-Risk Pancreatic Cancer

November 17 3 min read
In the phase II MASTERPLAN trial, the addition of stereotactic body radiotherapy (SBRT) to perioperative chemotherapy significantly reduced locoregional recurrence compared with chemotherapy alone in patients with high-risk, localized pancreatic cancer.

Latest in Pancreatic Cancer